BioAsia 2026 Highlights Hyderabad's Rising Life Sciences Hub

BioAsia 2026 Highlights Hyderabad's Rising Life Sciences Hub.webp

Hyderabad, February 17 – Telangana Chief Minister A. Revanth Reddy stated on Tuesday that Hyderabad has the potential to evolve from a global vaccine capital to a global life sciences capital.

While inaugurating BioAsia 2026 along with IT & Industries Minister D. Sridhar Babu, he emphasized that the annual event serves as a testament to Hyderabad's success as a life sciences hub.

He expressed confidence that BioAsia would soon gain recognition similar to the World Economic Forum held in Davos.

The Chief Minister highlighted Telangana's strengths, which will support its transition from a global vaccine capital to a global life sciences capital. He listed a strong vision, clear policies, the availability of highly qualified human resources, and excellent educational institutions as key strengths of Telangana.

He noted that Hyderabad is a global hub for Global Capability Centres (GCCs), with excellence in research and design.

The Chief Minister mentioned the recent launch of the Telangana Next-Gen Life Sciences Policy in Davos, the expansion of Genome Valley, the launch of 1Bio, a world-class research and innovation center, the acceleration of Green Pharma City, and the opening of various global capability centers in Hyderabad.

"In the last two years, we have received over ₹73,000 crore in investments in life sciences," he said.

Hyderabad is the preferred destination for setting up GCCs, building innovation engines, designing molecules and drugs, managing clinical analytics, building AI platforms, and driving digital manufacturing, he added.

Considering the massive turnout from around the world at BioAsia, the Chief Minister suggested that the conference could surpass its current name and be renamed as Bio-World.

He highlighted the presence of major thought and business leaders in pharmaceuticals, biosciences, biotechnology, bulk drugs, vaccines, and healthcare in Hyderabad.

He claimed that Hyderabad has emerged as a trusted, stable, and future-ready ecosystem. "From bulk drugs to biologics, from manufacturing to innovation, from India to the world, Telangana is moving up the value chain," he said.

Minister Sridhar Babu stated that the state is targeting $25 billion in life sciences investments and 5 lakh jobs by 2030, with a clear roadmap to position Telangana among the top three life sciences clusters globally. "Telangana is moving beyond supply-led manufacturing to solution-driven global leadership by building a ready-to-work talent pool in mRNA, gene editing, and AI-led drug discovery, while strengthening Hyderabad as a hub for next-generation innovation and medical tourism," he said.

BioAsia 2026 saw the participation of over 4,000 delegates representing 500 top companies from the life sciences ecosystem from all over the world.

The Chief Minister presented Prof. Bruce Levine from the University of Pennsylvania with the Genome Valley Excellence Award.
 
Tags Tags
bioasia biotechnology education genome valley global capability centres healthcare hyderabad innovation investment life sciences mrna pharmaceuticals research and development telangana vaccines
Back
Top